GNFT
Price
$3.87
Change
-$0.02 (-0.51%)
Updated
Jul 3 closing price
Capitalization
195.88M
77 days until earnings call
QURE
Price
$14.42
Change
+$0.14 (+0.98%)
Updated
Jul 3 closing price
Capitalization
789.47M
24 days until earnings call
Interact to see
Advertisement

GNFT vs QURE

Header iconGNFT vs QURE Comparison
Open Charts GNFT vs QUREBanner chart's image
Genfit SA
Price$3.87
Change-$0.02 (-0.51%)
Volume$330
Capitalization195.88M
uniQure
Price$14.42
Change+$0.14 (+0.98%)
Volume$328.15K
Capitalization789.47M
GNFT vs QURE Comparison Chart in %
Loading...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNFT vs. QURE commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNFT is a Buy and QURE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (GNFT: $3.87 vs. QURE: $14.42)
Brand notoriety: GNFT and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNFT: 5% vs. QURE: 21%
Market capitalization -- GNFT: $195.88M vs. QURE: $789.47M
GNFT [@Biotechnology] is valued at $195.88M. QURE’s [@Biotechnology] market capitalization is $789.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNFT’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • GNFT’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, GNFT is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNFT’s TA Score shows that 5 TA indicator(s) are bullish while QURE’s TA Score has 3 bullish TA indicator(s).

  • GNFT’s TA Score: 5 bullish, 4 bearish.
  • QURE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GNFT is a better buy in the short-term than QURE.

Price Growth

GNFT (@Biotechnology) experienced а +0.78% price change this week, while QURE (@Biotechnology) price change was +1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

GNFT is expected to report earnings on Sep 22, 2025.

QURE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($789M) has a higher market cap than GNFT($196M). GNFT YTD gains are higher at: 4.172 vs. QURE (-18.347).
GNFTQUREGNFT / QURE
Capitalization196M789M25%
EBITDAN/A-138.01M-
Gain YTD4.172-18.347-23%
P/E Ratio109.28N/A-
RevenueN/A20.2M-
Total CashN/A409M-
Total DebtN/A66.2M-
FUNDAMENTALS RATINGS
GNFT vs QURE: Fundamental Ratings
GNFT
QURE
OUTLOOK RATING
1..100
5350
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6137
P/E GROWTH RATING
1..100
293
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QURE's Valuation (79) in the Biotechnology industry is in the same range as GNFT (83). This means that QURE’s stock grew similarly to GNFT’s over the last 12 months.

QURE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GNFT (100). This means that QURE’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's SMR Rating (97) in the Biotechnology industry is in the same range as QURE (100). This means that GNFT’s stock grew similarly to QURE’s over the last 12 months.

QURE's Price Growth Rating (37) in the Biotechnology industry is in the same range as GNFT (61). This means that QURE’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for QURE (93). This means that GNFT’s stock grew significantly faster than QURE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNFTQURE
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
64%
Bullish Trend 5 days ago
70%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 5 days ago
74%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
85%
Aroon
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOAX19.320.18
+0.94%
Allspring Large Cap Core A
FOVAX27.080.25
+0.93%
First Trust/Confluence Small Cap Val A
MSCGX11.410.08
+0.71%
Mercer US Small/Mid Cap Equity Y3
PTPPX15.090.05
+0.33%
Principal International Equity R5
IGNCX13.25-0.01
-0.08%
Macquarie Natural Resources C

GNFT and

Correlation & Price change

A.I.dvisor tells us that GNFT and BCDA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNFT and BCDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
+2.11%
BCDA - GNFT
26%
Poorly correlated
+1.73%
QURE - GNFT
24%
Poorly correlated
+0.98%
FENC - GNFT
24%
Poorly correlated
+3.04%
GLPG - GNFT
23%
Poorly correlated
+0.98%
GUTS - GNFT
23%
Poorly correlated
+0.61%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NAMS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NAMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+0.98%
NAMS - QURE
50%
Loosely correlated
+4.69%
HOOK - QURE
46%
Loosely correlated
N/A
ABSI - QURE
41%
Loosely correlated
+2.97%
CRNX - QURE
40%
Loosely correlated
+1.22%
ZVRA - QURE
38%
Loosely correlated
N/A
More